[ad_1] According to the neurologist, a positive therapy study of progressive forms of MS at the secondary-chronic stage is also interesting. "The siponimod modulator S1P slowed the progression of these in a …
Read More »Göttingen researchers hope for the fight against multiple sclerosis
[ad_1] Göttingen. The disease Multiple sclerosis is a difficult destiny for many people. Researchers at the University Medical Center Göttingen want to develop new therapeutic and diagnostic approaches with a budget of …
Read More »